# Genesis MedTech acquires JC Medical for structural heart portfolio

Genesis MedTech Group completed the acquisition of JC Medical, a structural heart company developing transcatheter valve replacement products, including the J-Valve TAVR device.

- Type: Acquisition
- Announced: 2022-02-04
- Where: Singapore
- Status: completed
- Products: transcatheter aortic valve replacement device, J-Valve TA, J-Valve TF
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Genesis MedTech](https://endata.com/companies/45413.md) (acquirer)
- [JC Medical](https://endata.com/companies/60843.md) (target)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/genesis-medtech-acquires-jc-medical-creates-new-structural-heart-franchise-301471172.html), 2022-02-05: "Genesis MedTech Group (Genesis or Group) has completed the acquisition of JC Medical (JCM), a structural heart company that is primarily engaged in the design and development of transcatheter valve replacement products for the minimally invasive treatment of structural heart diseases."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.